A citation-based method for searching scientific literature

Yi-Long Wu, James Chih-Hsin Yang, Dong-Wan Kim, Shun Lu, Jianying Zhou, Takashi Seto, Jin-Ji Yang, Noboru Yamamoto, Myung-Ju Ahn, Toshiaki Takahashi, Takeharu Yamanaka, Allison Kemner, Debasish Roychowdhury, Jolanda Paolini, Tiziana Usari, Keith D Wilner, Koichi Goto. J Clin Oncol 2018
Times Cited: 129







List of co-cited articles
760 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical trials in children.
Pathma D Joseph, Jonathan C Craig, Patrina H Y Caldwell. Br J Clin Pharmacol 2015
123
1

Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
Jean-Yves Blay, Lin Shen, Yoon-Koo Kang, Piotr Rutkowski, Shukui Qin, Dmitry Nosov, Desen Wan, Jonathan Trent, Vichien Srimuninnimit, Zsuzsanna Pápai,[...]. Lancet Oncol 2015
58
1

Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants.
Sara Redaelli, Rocco Piazza, Roberta Rostagno, Vera Magistroni, Pietro Perini, Manuela Marega, Carlo Gambacorti-Passerini, Frank Boschelli. J Clin Oncol 2009
288
1

Overview and recent advances in the treatment of neuroblastoma.
Sarah B Whittle, Valeria Smith, Erin Doherty, Sibo Zhao, Scott McCarty, Peter E Zage. Expert Rev Anticancer Ther 2017
128
1

Tazemetostat: First Approval.
Sheridan M Hoy. Drugs 2020
58
1

A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
Mason Bond, Mark L Bernstein, Alberto Pappo, Kirk R Schultz, Mark Krailo, Susan M Blaney, Peter C Adamson. Pediatr Blood Cancer 2008
155
1

Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
Mahran Shoukier, Michal Kubiak, Jorge Cortes. Curr Oncol Rep 2021
1
100

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
Yael P Mossé, Stephan D Voss, Megan S Lim, Delphine Rolland, Charles G Minard, Elizabeth Fox, Peter Adamson, Keith Wilner, Susan M Blaney, Brenda J Weigel. J Clin Oncol 2017
165
1

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
Andrea Biondi, Martin Schrappe, Paola De Lorenzo, Anders Castor, Giovanna Lucchini, Virginie Gandemer, Rob Pieters, Jan Stary, Gabriele Escherich, Myriam Campbell,[...]. Lancet Oncol 2012
186
1

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.
Wayne L Furman, Lisa M McGregor, M Beth McCarville, Mihaela Onciu, Andrew M Davidoff, Sandy Kovach, Dana Hawkins, Valerie McPherson, Peter J Houghton, Catherine A Billups,[...]. Invest New Drugs 2012
22
4

Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failure.
David Gómez-Almaguer, Roxana Saldaña-Vázquez, Luz Tarín-Arzaga, Miguel Angel Herrera-Rojas, Alberto Vázquez-Mellado de Larracoechea, Olga Graciela Cantú-Rodríguez, Cesar Homero Gutiérrez-Aguirre, José Carlos Jaime-Pérez. Hematology 2016
7
14

The Potential Long-Term Comparative Effectiveness of Larotrectinib and Entrectinib for Second-Line Treatment of TRK Fusion-Positive Metastatic Lung Cancer.
Joshua A Roth, Josh J Carlson, Fang Xia, Todd Williamson, Sean D Sullivan. J Manag Care Spec Pharm 2020
6
16

Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients.
Burgess B Freeman, Najat C Daw, J Russell Geyer, Wayne L Furman, Clinton F Stewart. Cancer Invest 2006
34
2

Persistent complete response after single-agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma.
Tanzina Chowdhury, Kathryn Prichard-Jones, Neil J Sebire, Nelly Bier, Abraham Cherian, Maureen O Sullivan, Anne O'Meara, John Anderson. J Pediatr Hematol Oncol 2013
17
5

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Adele K Fielding, Jacob M Rowe, Georgina Buck, Letizia Foroni, Gareth Gerrard, Mark R Litzow, Hillard Lazarus, Selina M Luger, David I Marks, Andrew K McMillan,[...]. Blood 2014
217
1

Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.
Jeffrey H Lipton, Charles Chuah, Agnès Guerci-Bresler, Gianantonio Rosti, David Simpson, Sarit Assouline, Gabriel Etienne, Franck E Nicolini, Philipp le Coutre, Richard E Clark,[...]. Lancet Oncol 2016
135
1

A revised definition for cure of childhood acute lymphoblastic leukemia.
C H Pui, D Pei, D Campana, C Cheng, J T Sandlund, W P Bowman, M M Hudson, R C Ribeiro, S C Raimondi, S Jeha,[...]. Leukemia 2014
84
1

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.
Udai Banerji, D Ross Camidge, Henk M W Verheul, Roshan Agarwal, Debashis Sarker, Stan B Kaye, Ingrid M E Desar, Johanna N H Timmer-Bonte, S Gail Eckhardt, Karl D Lewis,[...]. Clin Cancer Res 2010
162
1

Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
Lia Gore, Pamela R Kearns, Maria Lucia de Martino, Lee, Carmino Antonio De Souza, Yves Bertrand, Nobuko Hijiya, Linda C Stork, Nack-Gyun Chung, Rocio Cardenas Cardos,[...]. J Clin Oncol 2018
38
2

New approaches to therapeutic drug development for childhood cancers.
Kevin Campbell, Clement Ma, Steven G DuBois. Curr Opin Pediatr 2020
1
100

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, Shengjie Wu, Azra H Ligon, Neal Lindeman, Anuradha Banerjee, Roger J Packer, Lindsay B Kilburn, Stewart Goldman,[...]. Lancet Oncol 2019
132
1

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Richard F Riedel, Karla V Ballman, Yao Lu, Steven Attia, Elizabeth T Loggers, Kristen N Ganjoo, Michael B Livingston, Warren Chow, Jennifer Wright, John H Ward,[...]. Oncologist 2020
4
25

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.
Frédéric Millot, Joelle Guilhot, André Baruchel, Arnaud Petit, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cecile Vérité, Christian Berthou, Claire Galambrun,[...]. Blood 2014
28
3

Depicting the genetic architecture of pediatric cancers through an integrative gene network approach.
Clara Savary, Artem Kim, Alexandra Lespagnol, Virginie Gandemer, Isabelle Pellier, Charlotte Andrieu, Gilles Pagès, Marie-Dominique Galibert, Yuna Blum, Marie de Tayrac. Sci Rep 2020
7
14


Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group.
Maura O'Leary, Mark Krailo, James R Anderson, Gregory H Reaman. Semin Oncol 2008
161
1

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
David Van Mater, Sridharan Gururangan, Oren Becher, Olivia Campagne, Sarah Leary, Joanna J Phillips, Jie Huang, Tong Lin, Tina Young Poussaint, Stewart Goldman,[...]. Pediatr Blood Cancer 2021
4
25

Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study.
Najat C Daw, Wayne L Furman, Clinton F Stewart, Lisa C Iacono, Mark Krailo, Mark L Bernstein, Janet E Dancey, Rose Anne Speights, Susan M Blaney, James M Croop,[...]. J Clin Oncol 2005
85
1

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Martin H Cohen, Grant Williams, John R Johnson, John Duan, Jogarao Gobburu, Atiqur Rahman, Kimberly Benson, John Leighton, Sung K Kim, Rebecca Wood,[...]. Clin Cancer Res 2002
326
1

Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.
Tara O Henderson, Smita Bhatia, Navin Pinto, Wendy B London, Patrick McGrady, Catherine Crotty, Can-Lan Sun, Susan L Cohn. J Clin Oncol 2011
76
1

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Jordi Bruix, Shukui Qin, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, Valeriy Breder,[...]. Lancet 2017
1

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Yael P Mossé, Megan S Lim, Stephan D Voss, Keith Wilner, Katherine Ruffner, Julie Laliberte, Delphine Rolland, Frank M Balis, John M Maris, Brenda J Weigel,[...]. Lancet Oncol 2013
423
1

Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.
Eudocia Q Lee, Alona Muzikansky, Dan G Duda, Sarah Gaffey, Jorg Dietrich, Lakshmi Nayak, Ugonma N Chukwueke, Rameen Beroukhim, Lisa Doherty, Caroline Kane Laub,[...]. Cancer Med 2019
8
12

Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor.
David S Hong, Kathleen N Moore, Johanna C Bendell, Daniel D Karp, Judy S Wang, Susanna V Ulahannan, Suzanne Jones, Wenjuan Wu, Gregory P Donoho, Yan Ding,[...]. Clin Cancer Res 2021
3
33

Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma.
Diana S Osorio, Jonathan L Finlay, Girish Dhall, Stewart Goldman, David Eisenstat, Robert J Brown. Pediatr Blood Cancer 2013
11
9

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Delphine Réa, Michael J Mauro, Carla Boquimpani, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Jane F Apperley, Andre Abdo,[...]. Blood 2021
4
25

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Andreas Hochhaus, Richard A Larson, François Guilhot, Jerald P Radich, Susan Branford, Timothy P Hughes, Michele Baccarani, Michael W Deininger, Francisco Cervantes, Satoko Fujihara,[...]. N Engl J Med 2017
501
1

Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects.
Jörg Thomas Hartmann, Michael Haap, Hans-Georg Kopp, Hans-Peter Lipp. Curr Drug Metab 2009
319
1


Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma.
Stephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, Emilie De Carli, Anne-Isabelle Bertozzi, Anne Pagnier, Fanny Fouyssac, Karsten Nysom, Isabelle Aerts, Pierre Leblond,[...]. Neurooncol Adv 2020
2
50

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.
Rastislav Bahleda, Antoine Italiano, Cinta Hierro, Alain Mita, Andres Cervantes, Nancy Chan, Mark Awad, Emiliano Calvo, Victor Moreno, Ramaswamy Govindan,[...]. Clin Cancer Res 2019
90
1

Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
C Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, Donna L Lancaster, Thomas Lehrnbecher, Vincent H J van der Velden, B Berna Beverloo, Monique L den Boer, Rob Pieters, Dirk Reinhardt,[...]. J Clin Oncol 2013
60
1

Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study.
Neil P Shah, Moshe Talpaz, Michael W N Deininger, Michael J Mauro, Ian W Flinn, Dale Bixby, Stephanie Lustgarten, Joseph M Gozgit, Tim Clackson, Christopher D Turner,[...]. Br J Haematol 2013
43
2

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.
Meinolf Suttorp, Philipp Schulze, Ingmar Glauche, Gudrun Göhring, Nils von Neuhoff, Markus Metzler, Petr Sedlacek, Eveline S J M de Bont, Adriana Balduzzi, Birgitte Lausen,[...]. Leukemia 2018
44
2

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
Partow Kebriaei, Rima Saliba, Gabriela Rondon, Alexandre Chiattone, Rajyalakshmi Luthra, Paolo Anderlini, Borje Andersson, Elizabeth Shpall, Uday Popat, Roy Jones,[...]. Biol Blood Marrow Transplant 2012
54
1

Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
Chandrajit P Raut, N Joseph Espat, Robert G Maki, Dejka M Araujo, Jonathan Trent, Toni Faith Williams, D Das Purkayastha, Ronald P DeMatteo. JAMA Oncol 2018
37
2

Palbociclib and Letrozole in Advanced Breast Cancer.
Richard S Finn, Miguel Martin, Hope S Rugo, Stephen Jones, Seock-Ah Im, Karen Gelmon, Nadia Harbeck, Oleg N Lipatov, Janice M Walshe, Stacy Moulder,[...]. N Engl J Med 2016
1

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
Stephen G O'Brien, François Guilhot, Richard A Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy Hughes,[...]. N Engl J Med 2003
1

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.
Jikui Guan, Susanne Fransson, Joachim Tetteh Siaw, Diana Treis, Jimmy Van den Eynden, Damini Chand, Ganesh Umapathy, Kristina Ruuth, Petter Svenberg, Sandra Wessman,[...]. Cold Spring Harb Mol Case Stud 2018
27
3

Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial.
Frédéric Millot, André Baruchel, Joelle Guilhot, Arnaud Petit, Thierry Leblanc, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Vérité, Christian Berthou,[...]. J Clin Oncol 2011
92
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.